Sign in
4

Changes in Ownership

Axsome Therapeutics, Inc. Filed Acc 0001104659-19-016570

Options or other derivatives

  • Director acquired 34,866 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
JEFFS ROGER Director 2019-03-19 Grant or award · Stock Option (Right to Buy) +34,866 34,866 D
Loading xslF345X03/a4.xml…